Corporate Governance
The board of SkinBioTherapeutics is committed to high standards of corporate governance across all our activities.
We follow the Corporate Governance Code published by the Quoted Companies Alliance in 2023 (the QCA Code). The board provides annual updates on compliance with the QCA Code in our Annual Report and on this page.
For investor enquiries, contact us at ir@skinbiotix.com.